Cutaneous Allodynia in Migraine

In the present work, we conduct a narrative review of the most relevant literature on cutaneous allodynia (CA) in migraine. CA is regarded as the perception of pain in response to non-noxious skin stimulation. The number of research studies relating to CA and migraine has increased strikingly over t...

Descripción completa

Detalles Bibliográficos
Autores: Mínguez-Olaondo, Ane|||0000-0002-7742-3920, Quintas, Sonia|||0000-0003-0622-8228, Morollón Sánchez-Mateos, Noemí|||0000-0003-4256-4210, López-Bravo, Alba|||0000-0002-2465-2316, Vila-Pueyo, Marta|||0000-0003-0652-2988, Grozeva, Vesselina, Belvís, Roberto|||0000-0002-2137-180X, Santos Lasaosa, Sonia|||0000-0002-4141-7705, Irimia, Pablo|||0000-0002-7238-0036
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:256023
Acceso en línea:https://ddd.uab.cat/record/256023
https://dx.doi.org/urn:doi:10.3389/fneur.2021.831035
Access Level:acceso abierto
Palabra clave:Cutaneous allodynia
Migraine
Migraine chronification
Risk factors
Treatment
Descripción
Sumario:In the present work, we conduct a narrative review of the most relevant literature on cutaneous allodynia (CA) in migraine. CA is regarded as the perception of pain in response to non-noxious skin stimulation. The number of research studies relating to CA and migraine has increased strikingly over the last few decades. Therefore, the clinician treating migraine patients must recognize this common symptom and have up-to-date knowledge of its importance from the pathophysiological, diagnostic, prognostic and therapeutic point of view. We performed a comprehensive narrative review to analyze existing literature regarding CA in migraine, with a special focus on epidemiology, pathophysiology, assessment methods, risk for chronification, diagnosis and management. PubMed and the Cochrane databases were used for the literature search. The prevalence of CA in patients with migraine is approximately 60%. The mechanisms underlying CA in migraine are not completely clarified but include a sensitization phenomenon at different levels of the trigemino-talamo-cortical nociceptive pathway and dysfunction of brainstem and cortical areas that modulate thalamocortical inputs. The gold standard for the assessment of CA is quantitative sensory testing (QST), but the validated Allodynia 12-item questionnaire is preferred in clinical setting. The presence of CA is associated with an increased risk of migraine chronification and has therapeutic implications. CA is a marker of central sensitization in patients with migraine that has been associated with an increased risk of chronification and may influence therapeutic decisions.